The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 6, pp. 713-719.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibley, M.
Right arrow Articles by Pugh, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibley, M.
Right arrow Articles by Pugh, C.


Research Articles

Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners

MC Shibley and CB Pugh

OBJECTIVE: To implement and evaluate pharmaceutical care services for patients with hyperlipidemias in the community pharmacy setting, to evaluate the results of a pharmaceutical care training process for pharmacists by using an assessment quiz, and to measure patient outcomes resulting from provision of pharmaceutical care to patients with hyperlipidemia. DESIGN: A prospective study was conducted over a 1-year period. Patients served as their own controls. SETTING: Two independent community pharmacies in Richmond, Virginia. PARTICIPANTS: Twenty-five adult patients with confirmed dyslipidemias completed the study. INTERVENTIONS: Study pharmacists assessed each patient and assisted in setting therapeutic goals; patients also completed a visit with a registered dietitian. Drug therapy recommendations were made to physicians by the pharmacist when appropriate. Follow-up was scheduled with the pharmacist to ensure positive outcomes and reduce adverse effects. MAIN OUTCOME MEASURES: Fasting lipoprotein profiles were measured initially and at 6 and 12 months. The SF-36 survey, the MacKeigan-Larson satisfaction survey, and a patient opinion survey were administered initially and at the conclusion of the study. RESULTS: Total cholesterol and low-density lipoprotein cholesterol values were significantly decreased at 12 months compared with either the baseline or 6-month values (p < 0.02). Significant improvement was found in several domains of the surveys; quality of life, patient satisfaction with pharmacy services, and patient opinions on the role of the pharmacist improved after the intervention. CONCLUSIONS: Pharmaceutical care may positively affect lipid values, quality of life, and patient satisfaction.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. Machado, N. Nassor, J. M Bajcar, G. C Guzzo, and T. R Einarson
Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management
Ann. Pharmacother., September 1, 2008; 42(9): 1195 - 1207.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
M. Tinelli, C. Bond, A. Blenkinsopp, M. Jaffray, M. Watson, P. Hannaford, and the Community Pharmacy Medicines Management Evalua
Patient Evaluation of a Community Pharmacy Medications Management Service
Ann. Pharmacother., December 1, 2007; 41(12): 1962 - 1970.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
M. L. Traverso, M. Salamano, C. Botta, M. Colautti, V. Palchik, and B. Perez
Questionnaire to assess patient satisfaction with pharmaceutical care in Spanish language
Int. J. Qual. Health Care, August 1, 2007; 19(4): 217 - 224.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
The Community Pharmacy Medicines Management Projec
The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease
Fam. Pract., April 1, 2007; 24(2): 189 - 200.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
C. Collins, A. Kramer, M. E. O'Day, and M. B. Low
Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.
Am. J. Health Syst. Pharm., September 15, 2006; 63(18): 1723 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
K. L. Olson and L. A. Potts
Role of the Pharmacist in the Management of Dyslipidemia
Journal of Pharmacy Practice, April 1, 2006; 19(2): 94 - 102.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. P Paulos, C. E A. Nygren, C. Celedon, and C. A Carcamo
Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia
Ann. Pharmacother., May 1, 2005; 39(5): 939 - 943.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. T. Tsuyuki, J. A. Johnson, K. K. Teo, S. H. Simpson, M. L. Ackman, R. S. Biggs, A. Cave, W.-C. Chang, V. Dzavik, K. B. Farris, et al.
A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
Arch Intern Med, May 27, 2002; 162(10): 1149 - 1155.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.